Cellectis reports Q1 EPS 0c, consensus (33c)

Reports Q1 revenue $6.5M, consensus $3.7M. “We are thrilled to have announced the closing of the additional equity investment of $140 million by AstraZeneca. This followed AstraZeneca’s initial payment of $105 million, composed of a $80 million equity investment and a $25 million upfront payment under our research collaboration.”